Veronica Iacovacci

The bioartificial pancreas (BAP): Biological, chemical and engineering challenges.

The bioartificial pancreas (BAP) represents a viable solution for the treatment of type 1 diabetes (T1D). By encapsulating pancreatic cells in a semipermeable membrane to allow nutrient, insulin and glucose exchange, the side effects produced by islets and whole organ transplantation-related immunosuppressive therapy can be circumvented. Several factors, mainly related to materials properties, capsule morphology and biological environment, play a key role in optimizing BAP systems. The BAP is an extremely complex delivery system for insulin. Despite considerable efforts, in some instances meeting with limited degree of success, a BAP capable of restoring physiological pancreas functions without the need for immunosuppressive drugs and of controlling blood glucose levels especially in large animal models and a few clinical trials, does not exist. The state of the art in terms of materials, fabrication techniques and cell sources, as well as the current status of commercial devices and clinical trials, are described in this overview from an interdisciplinary viewpoint. In addition, challenges to the creation of effective BAP systems are highlighted including future perspectives in terms of component integration from both a biological and an engineering viewpoint.

Advanced Micro-Nano-Bio Systems for Future Targeted Therapies

This article aims at highlighting the most recent and promising research trends, the open challenges and the possible routes to follow in the field of targeted therapy. A highly interdisciplinary viewpoint has been used, trying to evidence and discuss the different opportunities deriving from recent evolutions of nanotechnology, polymer science, robotics and biotechnology. The most used vectors for nanomedicine applications are described, together with the different action strategies reported in the literature, such as passive targeting, site-directed targeting and remotely triggerable drug delivery. Special emphasis is given to magnetically triggered systems and ultrasound-responsive materials, identified as the most promising paradigms. Key competences and system integration strategies derived from robotics are also introduced, focusing the attention on the crucial issue of achieving high controllability of the vector at the microand nano-scale. Finally, biocomponents are described, highlighting their potential as functional sensing elements or smart mechanisms to be integrated on board of advanced micro-nano therapeutic devices. The conclusion aims at depicting the importance of novel and improved targeted therapy strategies, to be coupled with the emerging world of predicting and personalized medicine. To this aim, a real merging of skills and approaches, derived from the aforementioned research fields, is recognized as highly desirable and rich of opportunities.

Untethered magnetic millirobot for targeted drug delivery.

This paper reports the design and development of a novel millimeter-sized robotic system for targeted therapy. The proposed medical robot is conceived to perform therapy in relatively small diameter body canals (spine, urinary system, ovary, etc.), and to release several kinds of therapeutics, depending on the pathology to be treated. The robot is a nearly-buoyant bi-component system consisting of a carrier, in which the therapeutic agent is embedded, and a piston. The piston, by exploiting magnetic effects, docks with the carrier and compresses a drug-loaded hydrogel, thus activating the release mechanism. External magnetic fields are exploited to propel the robot towards the target region, while intermagnetic forces are exploited to trigger drug release. After designing and fabricating the robot, the system has been tested in vitro with an anticancer drug (doxorubicin) embedded in the carrier. The efficiency of the drug release mechanism has been demonstrated by both quantifying the amount of drug released and by assessing the efficacy of this therapeutic procedure on human bladder cancer cells.

Magnetically driven microrobotic system for cancer cell manipulation.

Lab-on-a-chip applications, such as single cell manipulation and targeted delivery of chemicals, could greatly benefit from mobile untethered microdevices able to move in fluidic environments by using magnetic fields. In this paper a magnetically driven microrobotic system enabling the controlled locomotion of objects placed at the air/liquid interface is proposed and exploited for cell manipulation. In particular authors report the design, fabrication and testing of a polymeric thin film-based magnetic microrobot (called “FilmBot”) used as a support for navigating cancer cells. By finely controlling magnetic film locomotion, it is possible to navigate the cells by exploiting their adhesion to the film without affecting their integrity. Preliminary in vitro tests demonstrated that the magnetic thin film is able to act as substrate for T24 bladder cancer cells without affecting their viability and that film locomotion can be magnetically controlled (with a magnetic field and a gradient of 6 mT and 0.6 T/m, respectively) along specific directions, with a mean speed of about 3 mm/s.

Design and Development of a Mechatronic System for Noninvasive Refilling of Implantable Artificial Pancreas

The aim of this study is to contribute to the advancement of the mechatronic implantable artificial organs field by demonstrating the feasibility of a mechatronic refilling module to be used with implantable artificial organs (and particularly suitable for an artificial pancreas), and permitting a completely noninvasive refilling procedure without the need for dedicated surgical interventions. We described a refilling module, chronically interfaced with the duodenum wall, based on a magnetic switchable device, and able to reversibly dock an ingestible insulin carrier, whenever required. The capsule was provided with sensors in order to reveal its approach. A punching system was also developed with the aim of assuring a safe transfer of the insulin from the capsule to an implanted reservoir. The key components of the system were developed and tested. Finally, they were integrated in a preliminary prototype.

Magnetic Field-Based Technologies for Lab-on-a-Chip Applications

In the last decades, LOC technologies have represented a real breakthrough in the field of in vitro biochemical and biological analyses. However, the integration of really complex functions in a limited space results extremely challenging and proper working princi‐ ples should be identified. In this sense, magnetic fields revealed to be extremely promising. Thanks to the exploitation of external magnetic sources and to the integration of magnetic materials, mainly high aspect ratio micro-/nanoparticles, non-contact manipulation of biological and chemical samples can be enabled. In this chapter, magnetic field-based technologies, their basic theory, and main applications in LOC scenario will be descri‐ bed by foreseeing also a deeper interaction/integration with the typical technologies of microrobotics. Attention will be focused on magnetic separation and manipulation, by taking examples coming from traditional LOC devices and from microrobotics.

Nanocomposite thin films for triggerable drug delivery

ABSTRACT Introduction: Traditional drug release systems normally rely on a passive delivery of therapeutic compounds, which can be partially programmed, prior to injection or implantation, through variations in the material composition. With this strategy, the drug release kinetics cannot be remotely modified and thus adapted to changing therapeutic needs. To overcome this issue, drug delivery systems able to respond to external stimuli are highly desirable, as they allow a high level of temporal and spatial control over drug release kinetics, in an operator-dependent fashion. Areas covered: On-demand drug delivery systems actually represent a frontier in this field and are attracting an increasing interest at both research and industrial level. Stimuli-responsive thin films, enabled by nanofillers, hold a tremendous potential in the field of triggerable drug delivery systems. The inclusion of responsive elements in homogeneous or heterogeneous thin film-shaped polymeric matrices strengthens and/or adds intriguing properties to conventional (bare) materials in film shape. Expert opinion: This Expert Opinion review aims to discuss the approaches currently pursued to achieve an effective on-demand drug delivery, through nanocomposite thin films. Different triggering mechanisms allowing a fine control on drug delivery are described, together with current challenges and possible future applications in therapy and surgery.